China molecular diagnostics market is growing at a fast pace owing to rising prevalence of infectious diseases and cancer cases in the region coupled with growing geriatric population. It is projected that China molecular diagnostics market will exceed US$ 1.5 Billion by the end of 2022. Molecular diagnostics are extremely effective in diagnosing and preventing diseases, offering accurate and precise healthcare interventions in the early stages of diseases.

China Molecular Diagnostics Segments Market

China molecular diagnostics market has been segmented into three major categories: Oncology Testing, Infectious Disease Testing and Genetic Disease Testing. Further, Oncology Testing has been segmented into three major categories: Breast Cancer Testing, Colorectal Cancer Testing and Prostate Cancer Testing. Infectious Disease Testing has been segmented into two major categories, namely, virology and HPV and Genetic Testing has been segmented into Blood Screening and HLA.

China Infectious Disease test market; Virology tests accounts for the highest market share. Furthermore, our analysis found that nearly 300 million molecular diagnostic tests will be performed in China by the end of 2022 of which Virology accounts for one of the most performed tests segments.

Increasing incidence of contagious diseases along with cancer cases and the rise of the private healthcare sector in China, with the development of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region are some of the contributors which are anticipated to drive the molecular diagnostics market over the forecast period.

• What is China molecular diagnostics market size from 2011 to 2022?• What is China molecular diagnostics tests volume from 2011 to 2022?• What are China molecular diagnostics segments market & Forecast? • What are the growth drivers of Molecular diagnostics in China?

The China Petrochemicals Report has been researched at source, and features BMI Research's market assessment and independent forecasts for key petrochemicals sub-sectors. The report also analyses the impact of regulatory changes, recent developments and the background macroeconomic outlook and featu

BMI View: China's long-term crude oil and liquids output will remain on a
firm downtrend as low oil prices slowdown exploration and render certain
high-cost mature and unconventional plays uneconomic. Outlook is more positive
for natural gas, as the government seeks to increase the share of ga

BMI View: China will become a leading medical research hub within the Asia
Pacific region. This will be largely led by multinational pharmaceutical firms
as they seek to tap the large talent pool within the country and develop
treatments 'in China, for China'. The local industry, while stil

BMI View: Operator strategies will continue to chime with the government's directive to drive uptake of wireline broadband and machine-to-machine (M2M) connections. However, this means that even as subscription numbers rise, the prices of basic services will be compressed and operators will derive p

Driven by a surge in sales volume of new energy vehicles in China, the upstream material- lithium carbonate was in short supply in the fourth quarter of 2015 with soaring prices. Global lithium carbonate output increased by 12.3% year on year to 202,800 tons in 2015 and is expected to arrive at 244,

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Why Choose Market Reports On China?

100% Service Guarantee Accurate Reports On Time.

Fully Secure Payment Don't have to worry about online Payment.

Live Help Corner You Can get Help any Time You need, Just One Click away